Tumor vasculature targeting: a generally applicable approach for functionalized nanomaterials.
about
Surface engineering of graphene-based nanomaterials for biomedical applicationsTheranostic nanoparticlesEngineering of hollow mesoporous silica nanoparticles for remarkably enhanced tumor active targeting efficacyIntrinsically radiolabeled nanoparticles: an emerging paradigm.In vivo tumor vasculature targeted PET/NIRF imaging with TRC105(Fab)-conjugated, dual-labeled mesoporous silica nanoparticles.VEGFR targeting leads to significantly enhanced tumor uptake of nanographene oxide in vivo.In Vivo Tumor Vasculature Targeting of CuS@MSN Based Theranostic Nanomedicine.Scintillating Nanoparticles as Energy Mediators for Enhanced Photodynamic TherapyLong circulating reduced graphene oxide-iron oxide nanoparticles for efficient tumor targeting and multimodality imaging.Coadministration of Vascular Disrupting Agents and Nanomedicines to Eradicate Tumors from Peripheral and Central Regions.Cancer theranostics with ⁶⁴Cu/¹⁷⁷Lu-loaded liposomes.Intracellular delivery and ultrasonic activation of folate receptor-targeted phase-change contrast agents in breast cancer cells in vitro.Enhanced and Selective Antiproliferative Activity of Methotrexate-Functionalized-Nanocapsules to Human Breast Cancer Cells (MCF-7).Big Potential from Small Agents: Nanoparticles for Imaging-Based Companion Diagnostics.Ultrasmall targeted nanoparticles with engineered antibody fragments for imaging detection of HER2-overexpressing breast cancerGeneral synthesis of silica-based yolk/shell hybrid nanomaterials and tumor vasculature targetingTumor Microenvironment Targeted Nanotherapy
P2860
Q26853158-624484C9-7CE8-476F-8456-5A7352496695Q28650348-28F9043F-423F-4794-B44E-8CD936B489D7Q33687218-306D3C29-8912-4D4C-AA04-8DA200936E07Q34315359-FCEE4617-2982-4FD3-BB25-9FCC9390ADC4Q34446399-F3867B50-3E25-4145-B5A4-6736787CFA64Q34650180-68DFB837-3DE2-4CF5-9643-D23A93746A04Q35554806-CA794071-868A-435F-A1E8-5A9AD2628237Q36839885-412FD620-3410-467C-9E83-A190E0BB8465Q37033916-B9D43E13-D0A2-4B53-8920-D3E1EB79D062Q38881452-B9436FBE-503A-48A9-A822-7BB4AACE6BA5Q42925462-4AB0A747-6534-466F-B5F8-27C69C583393Q44867216-C08CD174-43B7-42B4-80BE-666C3CD0297FQ48310691-9DA6C850-930B-4E9E-B651-86CE8B508AE5Q50422486-EA2088FD-D4E7-401C-AAAB-2331AC52A6BDQ57295430-D2932C0C-E765-46CA-A3CD-1FBC973F0637Q58560988-2F07531A-D4CE-429A-9CFA-E3DDC47CDD1AQ59133567-944EF745-7C06-4F1E-BC74-41E93587FAF3
P2860
Tumor vasculature targeting: a generally applicable approach for functionalized nanomaterials.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Tumor vasculature targeting: a ...... functionalized nanomaterials.
@ast
Tumor vasculature targeting: a ...... functionalized nanomaterials.
@en
Tumor vasculature targeting: a ...... functionalized nanomaterials.
@nl
type
label
Tumor vasculature targeting: a ...... functionalized nanomaterials.
@ast
Tumor vasculature targeting: a ...... functionalized nanomaterials.
@en
Tumor vasculature targeting: a ...... functionalized nanomaterials.
@nl
prefLabel
Tumor vasculature targeting: a ...... functionalized nanomaterials.
@ast
Tumor vasculature targeting: a ...... functionalized nanomaterials.
@en
Tumor vasculature targeting: a ...... functionalized nanomaterials.
@nl
P2860
P356
P1433
P1476
Tumor vasculature targeting: a ...... functionalized nanomaterials.
@en
P2093
P2860
P304
P356
10.1002/SMLL.201303627
P577
2014-03-03T00:00:00Z